Organicell Regenerative Medicine (BPSR) Short Interest Ratio & Short Volume

Short interest is the volume of Organicell Regenerative Medicine shares that have been sold short but have not yet been covered or closed out. As of October 29th, traders have sold 70,800 shares of BPSR short. Learn More on Organicell Regenerative Medicine's current short interest.

Organicell Regenerative Medicine saw a increase in short interest in October. As of October 29th, there was short interest totaling 70,800 shares, an increase of 2,978.3% from the previous total of 2,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

As of the most recent reporting period, the following stocks had the largest short interest positions: S&P Global Inc. ($8.61 billion), Advanced Micro Devices, Inc. ($8.44 billion), Charter Communications, Inc. ($5.26 billion), Canadian Pacific Kansas City Limited ($5.13 billion), Wayfair Inc. ($4.34 billion), Uber Technologies, Inc. ($3.69 billion), Palo Alto Networks, Inc. ($3.35 billion), Teladoc Health, Inc. ($3.11 billion), eBay Inc. ($2.91 billion), and Etsy, Inc. ($2.63 billion). View all of the most shorted stocks.

Short selling BPSR is an investing strategy that aims to generate trading profit from Organicell Regenerative Medicine as its price is falling. BPSR shares are trading down $0.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Organicell Regenerative Medicine occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BPSR, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BPSR, twice per month. The most recent reporting period available is October, 29 2021.